Wyss Institute at Harvard is an institute for research at Harvard University for developing bioinspired materials and medical devices.
The Institute tries to research how to emulate the biological principles of self assembly, organization, and regulation in order to further the development of commercial technological solutions for healthcare, energy, architecture, robotics, and manufacturing industries. As of September 2019, the Wyss Institute at Harvard has published 2,145 scientific papers, filed for 2,736 patents, received 58 licenses, and created 31 startup companies.
The Wyss Institute has 9 major areas of focus which are: adaptive material technologies, immuno-materials, bioinspired soft robotics, living cellular devices, bioinspired therapeutics & diagnostics, molecular robotics, 3D organ engineering, diagnostic accelerator, and synthetic biology.
There are 12 academic institutions and hospitals collaborating with the Wyss Institute at Harvard, they are: University of Massachusetts Medical School, Harvard John A. Paulson School of Engineering and Applied Sciences, Spaulding Rehabilitation Hospital, Boston Children's Hospital, Harvard University graduate School of Design, Beth Israel Deaconess Medical Center, Brigham and Women's hospital, Tufts University, Massachusetts General Hospital, Massachusetts Institute of Technology, Dana-Farber Cancer institute, Harvard Graduate School of Education, Harvard Medical School, University of Zurich, Boston University, and Harvard Faculty of Arts and Science.
